Fig. 2From: Novel drugs that target the metabolic reprogramming in renal cell cancerConnections between the PI3K- and metabolic pathways are shown. Given their central role in the pathogenesis of RCC, p110alpha, Akt, and mTORC1 are labeled orange Back to article page